A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis
Clinical trial NCT03727451 · COMPLETED
Trial details
- NCT number
- NCT03727451
- Sponsor
- Bellerophon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2021-09-07
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.